Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Q32 Bio (QTTB) Asset Utilization Ratio (2018 - 2024)

Q32 Bio's quarterly Asset Utilization Ratio came in at 0.01 in Q3 2024, down 120.87% year-on-year from 0.06 in Q4 2023, and down 429.49% quarter-over-quarter from 0.0 in Q2 2024.

Q32 Bio has reported Asset Utilization Ratio for 7 years, with the latest figure at 0.01 in Q3 2024.

  • For the quarter ending Q3 2024, Asset Utilization Ratio fell 120.87% year-over-year to 0.01; the trailing twelve-month figure through Sep 2024 stood at 0.01 (down 120.87% YoY), and the FY2025 full-year result was 0.7, changed N/A from the prior year.
  • Asset Utilization Ratio for Q3 2024 stood at 0.01, down from 0.0 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.15 in Q4 2021, with the low at 0.01 in Q3 2024.
  • Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.02 recorded in 2022.
  • Year-over-year, Asset Utilization Ratio surged 1804.26% in 2021 and plunged 120.87% in 2024.
  • Tracing QTTB's Asset Utilization Ratio over 5 years: stood at 0.01 in 2020, then surged by 1298.06% to 0.15 in 2021, then sank by 91.49% to 0.01 in 2022, then soared by 444.15% to 0.07 in 2023, then plunged by 116.73% to 0.01 in 2024.
  • The last three Asset Utilization Ratio figures came in at 0.01 (Q3 2024), 0.0 (Q2 2024), and 0.04 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.60
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.47
7 Evaxion A 62.56 Bn 62.54 Bn - 0.29
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.37
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.85
10 Q32 Bio 162.94 Mn 112.19 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2024 -0.01
Jun 30, 2024 0.00
Mar 31, 2024 0.04
Dec 31, 2023 0.07
Sep 30, 2023 0.06
Jun 30, 2023 0.04
Mar 31, 2023 0.03
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.02
Dec 31, 2021 0.15
Sep 30, 2021 0.14
Jun 30, 2021 0.13
Mar 31, 2021 0.13
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.01
Mar 31, 2020 0.01
Dec 31, 2019 0.01
Sep 30, 2019 0.01
Jun 30, 2019 0.01
Mar 31, 2019 0.02
Dec 31, 2018 0.02